Combo Tx Gets Perfect Score in Lymphoma MedPage Today WASHINGTON -- A three-drug combination -- vorinostat (Zolinza), cladribine, and rituximab (Rituxan) -- led to a 100% response rate in a small study of patients with advanced mantle cell lymphoma. All of the 37 patients in the study had at least a ... |
